|
Product Details:
Payment & Shipping Terms:
|
| CAS: | 156223-05-1 | Product Name: | 3-(2,4-dimethoxybenzylidene)anabaseine |
|---|---|---|---|
| Type: | Pharmaceutical Raw Materials | Appearance: | White Powder |
| Usage: | For Nootropics | Alias: | GTS 21 2HCl(DMXBA) |
| Assay: | 99% | Key Words: | GTS 21 |
| High Light: | brain nootropics,memory enhancing supplements |
||
Details :
Chemical name 3-[(3E)-3-[(2,4-dimethoxyphenyl)methylidene]-5,6-dihydro-4H-pyridin-2-yl]pyridine
Synonyms 3-(2,4-dimethoxy-benzylidene)anabaseine
Other name:DMBX-A
Cas: 156223-05-1
MF:C19H20N2O2
MW:308.374
Appearance: White powder
Purity:99%
GTS-21 (DMBX-A) is a derivative of the natural product anabaseine that acts as a partial agonist at neural nicotinic acetylcholine receptors. It binds to both the α4β2 and α7 subtypes, but activates only the α7 to any significant extent
Both GTS-21 itself and its demethylated active metabolite 4-OH-GTS-21 display nootropic and
neuroprotective effects, and GTS-21 is being investigated for the treatment ofAlzheimer's disease,
nicotine dependence,and, most significantly, for schizophrenia.
GTS-21 (DMXB-A) is being investigated for the treatment of Alzheimer's disease,nicotine dependence
99% 3-(2,4-dimethoxybenzylidene)anabaseine Manufacturer CAS 156223-05-1
Contact Person: Linda Yang
Tel: +8618874586545
